NasdaqHealth CarePharmaceutical PreparationsTEL AVIV, Israel

Chemomab Therapeutics Ltd. CMMB

Ask your AI

ADR: the number of shares per ADR isn’t known yetCIK 1534248

Insider trades, 12 mo

2 buys · 2 sells

$6,516 sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

3 added · 4 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in Chemomab Therapeutics Ltd.'s latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

4 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 28, 2026. Insiders have two business days to file.

Recent insider trades

Neil Harris Cohen Director	Aug 28 Form 4 ↗	Sale	−$2,800 1,000 sh @ $2.80	-41.6%
Neil Harris Cohen Director	Aug 27 Form 4 ↗	Sale	−$3,716 1,304 sh @ $2.85	-41.6%
George Adi Mor Chief Executive Officer, Director	May 29 Form 4 ↗	Buy	+$10.2K 4,926 sh @ $2.08	-23.2%
George Adi Mor Chief Executive Officer, Director	May 29 Form 4 ↗	Buy	+$10,000 4,878 sh @ $2.05	-23.2%

All CMMB insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

196,587 shares

12 funds report CMMB. Values checked against market prices.

Q3 2026. 5 new, 3 added to, 4 trimmed, 6 exited since Q2 2026.

Top 13F holders
#
1	Kestra Private Wealth Services, LLC 13F ↗	77,153	$91.8K	+25.0%
2	Rhumbline Advisers 13F ↗	30,070	$35.8K	-1.5%
3	StoneX Group Inc. 13F ↗	18,620	$29.8K	New
4	Philadelphia Investment Partners, LLC 13F ↗	22,566	$26.9K	+50.4%
5	Jane Street Group, LLC 13F ↗	19,637	$23.4K	New
6	SmartHarvest Portfolios, LLC 13F ↗	13,031	$15.5K	New
7	Renaissance Technologies LLC 13F ↗	10,328	$12.3K	New
8	BNP Paribas Financial Markets 13F ↗	3,300	$3,927	-51.5%
9	Morgan Stanley 13F ↗	1,600	$1,904	-55.2%
10	Nuveen, LLC 13F ↗	235	$378	New

Download CSV Every fund that holds CMMB, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Chemomab Therapeutics Ltd. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Chemomab Therapeutics Ltd. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q3 2025	10	—	390,310	$1.0M
Q4 2025	14	+4	367,379	$606.1K
Q1 2026	15	+1	351,560	$551.9K
Q2 2026	13	-2	379,833	$615.3K
Q3 2026	12	-1	196,587	$241.7K

Each point is a quarter-end, from Q3 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (16385C203). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q3 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes7 in 12 mo 8-K eventsNone in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Pending deal1 deal filed lately IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Chemomab Therapeutics Ltd.
Address: KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Phone: 972-77-331-0156
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: Israel
Listed as: CMMB (Nasdaq)
Former names: Anchiano Therapeutics Ltd. (until 2021); BioCancell Ltd. (until 2015)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.53+$0.13 (+9.29%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $1.00 · High $1.53Nov 13, 2026

Aug 13, 2026Low $1.00 · High $2.83Nov 13, 2026

Nov 13, 2025Low $1.00 · High $2.83Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.